2013-04-30-世界卫生组织-Sixth_report_of_the_Strategic_and_Technical_Advisory_Group_for_Neglected_Tropical_Diseases_STAG-NTDs_77页_1mb

Report of the Sixth Meeting of the WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases

Summary

Meeting Dates: 29–30 April 2013, WHO Headquarters, Geneva, Switzerland
Key Highlights:

Day 1: Key Discussions and Recommendations

1. NTD Department Update (Dr. Lorenzo Savioli):

   • Significant progress towards eradicating dracunculiasis and yaws, and good progress in eliminating human African trypanosomiasis and blinding trachoma.
   • Challenges: Slow scaling up of preventive chemotherapy coverage, particularly for lymphatic filariasis in the African Region, and the need for enhanced capacity to manage severe adverse events from drug use.

2. Capacity Strengthening (WG-CS) (Prof. David Molyneux):

   • Recommended prioritizing capacity building in highly populous countries, utilizing eLearning and mobile apps for sustainable resource access.
   • Proposed activities: Training programs for national program managers, inventory development for laboratories, and harmonized partner efforts.

3. Economics of NTD Control (Prof. Deborah McFarland):

   • Need for standardized costing methodologies and investment in evidence for economic impact.
   • Suggested options: Harmonizing existing informal networks or creating a dedicated working group for economic analysis.

4. Special Programme for Research and Training (TDR) (Dr. John Reeder):

   • Research focus on drug resistance, diagnostics, and implementation studies to support NTD control strategies.

5. Access to Essential Medicines (WGA) (Prof. Nilanthi de Silva):

   • Urged mobilizing resources for prequalification of key drugs (praziquantel, albendazole, liposomal amphotericin B) and collaboration with regulatory authorities for quality assurance.

6. Monitoring Drug Efficacy (WG-MDE) (Dr. Antonio Montresor):

   • Developed guidelines for assessing drug efficacy and identified the need for molecular markers of resistance.
   • Recommended annual meetings to maintain progress and integrate findings into field responses.

7. Monitoring and Evaluation (WG-M&E) (Dr. Sam Zaramba):

   • Prioritized improving data quality, harmonizing tools for large-scale implementation, and advancing integrated transmission assessments.

Day 2: Follow-Up Discussions and Recommendations

• Vector Control Integration (Dr. Dirk Engels):

  • Proposed merging certain working groups to streamline operations, including creating new groups for economics and dengue.

• Dengue Update (Dr. Ronald Rosenberg):

  • Supported WHO’s dengue strategy, emphasizing integrated surveillance, vector control, and advocacy.

• Rabies Elimination (Dr. François-Xavier Meslin):

  • Endorsed the global strategy for rabies elimination, calling for national commitments and funding.

• Neglected Zoonotic Diseases (WG-NZD) (Prof. Malika Kachani):

  • Recommended embedding NZDs into NTD control programs and fostering "One Health" collaboration.

• Yaws Eradication (Dr. Kingsley Asiedu):

  • Noted challenges in surveillance and funding, stressing the need for political commitment and sustained resources.

• HAT Control (Dr. Anne Moore):

  • Outlined progress in HAT diagnostics and treatment, emphasizing the need for better surveillance.

Follow-Up Actions:

1. Strengthen national partnerships for integrated NTD programs.
2. Accelerate capacity building, especially in populous regions.
3. Harmonize monitoring tools and data systems across countries.
4. Advocate for funding and policy support for NTD control.

Attachments:

• List of participants and working group reports included.

STAG Endorsement: Recommendations from all working groups were endorsed to support the WHO roadmap for NTD control.